Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally ...

International assessments show Iran ranks first in the Islamic world in gene therapy, CRISPR, RNA interference, and cell therapy, securing a leading regional scientific position.

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. | Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. GSK has decided not ...

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

In the lead-up to its upcoming quarterly earnings report, Eli Lilly and Company is making significant moves to bolster its development pipeline. The pharmaceuti ...

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.

Hologen, an AI biotech co-founded by former Google CEO Eric Schmidt, is seeking to raise $150 million in a Series A round at ...

Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...

Market OverviewThe global cell and gene therapy market is undergoing rapid and transformative growth, reflecting its increasing importance in modern healthcare.The market is projected to expand at a ...

Fixing gene defects with designer DNA is on the horizon after Google DeepMind launched a pioneering new AI tool.

REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC ...